Myasthenia Crisis Vs Cholinergic Crisis: Challenges in Crisis Management Without Plasmapheresis or Intravenous Immunoglobulin (IVIG)
Introduction: Myasthenia gravis (MG) is an acquired autoimmune disorder clinically characterized by skeletal muscle weakness & fatigability on exertion with prevalence as high as 2–7 in 10,000 and women are affected more frequently than men (~3:2). Over 12-16% of generalized MG patients experien...
Main Authors: | Lila Tri Harjana, Hardiono Hardiono |
---|---|
Format: | Article |
Language: | English |
Published: |
Universitas Airlangga, Faculty of Medicine
2020-07-01
|
Series: | Indonesian Journal of Anesthesiology and Reanimation (IJAR) |
Subjects: | |
Online Access: | https://e-journal.unair.ac.id/IJAR/article/view/19850 |
Similar Items
-
Myasthenia Gravis and Pregnancy
by: Papish M., et al.
Published: (2018-12-01) -
High-dose steroids versus standard treatment for myasthenic crisis: A single-center, longitudinal, 12-year retrospective study
by: Jovann Frederick Figuera Rabor, et al.
Published: (2023-01-01) -
Management of Myasthenia Gravis
by: Sudhir Venkataramaiah, et al.
Published: (2019-06-01) -
Comparing Plasmapheresis plus IVIg with Plasmapheresis plus IVIg plus Rituximab on the Management of Suspicious Antibody-Mediated Acute Rejection in Kidney Transplant Recipients
by: F Ahmadi, et al.
Published: (2019-07-01) -
Case report: Recovery from refractory myasthenic crisis to minimal symptom expression after add-on treatment with efgartigimod
by: Keiko Watanabe, et al.
Published: (2024-01-01)